October 22, 2021 Acad, Gov/Utilities Bio/Pharma/CRO Clinical Research/Diagn. PR/Corporate

Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)

Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1 The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study. This new test expands Roche’s... Read more

October 20, 2021 Bio/Pharma/CRO M&A, Partnerships

Waters and University of Delaware Announce Bioprocessing Innovation Partnership, Plan 2022 Opening of Immerse Delaware Lab

Partnership will focus on developing analytical solutions to better characterize bioprocesses towards improved quality, yields and efficiency News Summary: Waters and University of Delaware announce a multi-year collaboration to develop technology for analytical characterization of manufacturing processes for biologics and novel modalities. Waters’ staff and university researchers will co-locate at Immerse™ Delaware, an Innovation and... Read more

October 18, 2021 Bio/Pharma/CRO Cell Analysis Tools Lab Top-10 Life Science Tools

PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis

Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 18, 2021– PerkinElmer, Inc. (NYSE: PKI) and Honeycomb Biotechnologies, Inc., announced today the commercial launch of the first of its kind HIVETM scRNAseq Solution for single-cell isolation and analysis. The HIVE solution leverages a... Read more

October 14, 2021 Bio/Pharma/CRO Lab Equipment Lab Top-10 M&A, Partnerships

PerkinElmer Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery

Will provide automated protein characterization, cell imaging and cell counting technologies, along with expertise and training October 14, 2021 WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today announced it is collaborating with leading life science incubators LabCentral in Boston, Massachusetts and MBC BioLabs in San Francisco, California to provide... Read more

October 4, 2021 Bio/Pharma/CRO Informatics & Software Lab Top-10 Liq. Handling & Robotics

PerkinElmer Introduces Next Generation Cell Image Analysis and Management Software Platform to Help Streamline Drug Discovery Decision Making

Signals Image Artist helps scientists process and analyze 3D cell imaging, phenotypic and cell painting data in hours vs. days or weeks October 4, 2021 WHAT: PerkinElmer, Inc ., a global leader committed to innovating for a healthier world, today announced the launch of Signals Image Artist™ software, a next generation image analysis and management... Read more

September 30, 2021 Bio/Pharma/CRO Clinical Research/Diagn.

Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load within seven days of treatment in patients hospitalised with COVID-19

Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with COVID-19 who did not require high-flow oxygen or mechanical ventilation at baseline Clinical data complement previous findings in hospitalised setting, including from United Kingdom (UK) University of Oxford-led RECOVERY trial Basel, 30 September 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

September 13, 2021 Bio/Pharma/CRO Liq. Handling & Robotics M&A, Partnerships

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

Oxford and Zurich – 13 September 2021 – Life Science Newswire – Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate synthetic chemistry. Representing chemical reactions via SMILES (Simplified Molecular... Read more

September 1, 2021 Bio/Pharma/CRO Informatics & Software Product Launch

SCIEX builds on cadence of innovation in biopharma with Biologics Explorer

New application software enables protein characterization analysis for the ZenoTOF 7600 system September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, launches Biologics Explorer software, enabling customers to acquire insights from their high-resolution protein characterization data, and reach decisions quickly and confidently on the most important... Read more

August 18, 2021 Acad, Gov/Utilities Bio/Pharma/CRO Clinical Research/Diagn. PAI Top-10 PR/Corporate

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1, 2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the first-of-its-kind VENTANA MMR RxDx Panel helps determine which solid tumour patients may benefit from GSK immunotherapy. Roche/GSK collaboration... Read more